ResearcherInstitut BergoniéActive in the last 2 years
Jeanne Léna
Matched on OpenAlex author ID A5109718739. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2024: 1 paper · 2025: 1 paper
Papers 2
- Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients. Co-author DOI 10.1016/j.ejca.2024.115197↗
- Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should KRAS mutation research be recommended in everyday practice? Co-author DOI 10.1177/17562848231224943↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Antoîne Italiano · 2 shared papers, 2024–2025 · strength 0.46
- Paper Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 pat… DOI 10.1016/j.ejca.2024.115197↗
- Paper Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should KRAS mutation research b… DOI 10.1177/17562848231224943↗
- Simon Pernot · 2 shared papers, 2024–2025 · strength 0.46
- Paper Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 pat… DOI 10.1016/j.ejca.2024.115197↗
- Paper Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should KRAS mutation research b… DOI 10.1177/17562848231224943↗
- Lola‐Jade Palmieri · 2 shared papers, 2024–2025 · strength 0.46
- Paper Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 pat… DOI 10.1016/j.ejca.2024.115197↗
- Paper Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should KRAS mutation research b… DOI 10.1177/17562848231224943↗
- Marianne Fonck · 1 shared paper, 2024 · strength 0.21
- Dominique Béchade · 1 shared paper, 2024 · strength 0.21
- Gilles Roseau · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.